Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Antilymphocyte globulin for myelodysplastic syndrome.

Tichelli A, Gratwohl A, Wuersch A, Nissen C, Speck B.

Br J Haematol. 1988 Jan;68(1):139-40. No abstract available.

PMID:
3345291
2.

Treating patients of myelodysplastic syndrome with antithymocytic globulin--should we be more selective?

Madkaikar M, Ghosh K.

Blood. 2003 Nov 15;102(10):3851-2; author reply 3852. No abstract available.

3.

Favourable response to splenectomy in familial myelodysplastic syndrome.

Abdul-Wahab J, Naznin M, Suhaimi A, Amir-Hamzah AR.

Singapore Med J. 2007 Jul;48(7):e206-8.

4.

Antithymocyte globulin for patients with myelodysplastic syndrome.

Molldrem JJ, Caples M, Mavroudis D, Plante M, Young NS, Barrett AJ.

Br J Haematol. 1997 Dec;99(3):699-705.

PMID:
9401087
5.

Antithymocyte globulin has limited efficacy and substantial toxicity in unselected anemic patients with myelodysplastic syndrome.

Steensma DP, Dispenzieri A, Moore SB, Schroeder G, Tefferi A.

Blood. 2003 Mar 15;101(6):2156-8. Epub 2002 Oct 31.

6.

Immunosuppressive therapy for hypoplastic myelodysplastic syndrome.

Biesma DH, van den Tweel JG, Verdonck LF.

Cancer. 1997 Apr 15;79(8):1548-51.

PMID:
9118037
7.

Recovery from severe idiopathic aplastic pancytopenia following antithymocyte globulin therapy.

Ansari A, Grotte M.

Minn Med. 1986 Jun;69(6):361-4. No abstract available.

PMID:
3489162
8.

Anti-thymocyte globulin therapy induced a spurious increase of fibrinogen degradation products in hypoplastic myelodysplastic syndrome.

Yahata Y, Isobe Y, Sasaki M, Oshimi K, Sugimoto K.

Eur J Haematol. 2009 May;82(5):404. doi: 10.1111/j.1600-0609.2008.01200.x. Epub 2008 Dec 18. No abstract available.

PMID:
19191866
9.

Successful immunosuppressive therapy for a child with Myelodysplastic syndrome.

Orimoto M, Maeda M, Cai LZ, Hayakawa J, Ueda T, Migita M, Asano T.

Med Pediatr Oncol. 2003 May;40(5):334-5. No abstract available.

PMID:
12652627
10.

Favourable response to antithymocyte globulin therapy in resistant acute graft-versus-host disease.

Tagliabue A, Corti P, ViganĂ² E, Bonanomi S, Uderzo C.

Bone Marrow Transplant. 2005 Sep;36(5):459. No abstract available.

PMID:
15980883
11.

[Outcome of immunosuppressive therapy for myelodysplastic syndromes: results of 12 cases from a single institution].

Miyata A, Yasuda Y, Fujii S, Kikuchi T.

Rinsho Ketsueki. 2002 Oct;43(10):911-7. Japanese.

PMID:
12462026
12.

[Myelodysplastic syndrome].

Urabe A.

Gan To Kagaku Ryoho. 2005 Mar;32(3):287-91. Review. Japanese.

PMID:
15791810
13.

Hematologic responses of patients with MDS to antithymocyte globulin plus etanercept correlate with improved flow scores of marrow cells.

Deeg HJ, Jiang PY, Holmberg LA, Scott B, Petersdorf EW, Appelbaum FR.

Leuk Res. 2004 Nov;28(11):1177-80.

PMID:
15380342
14.
15.

Myelodysplastic syndrome.

Nakao S, Deeg HJ, Ishikawa T, Marsh J, List A, Tomonaga M.

Int J Hematol. 2005 Dec;82(5):412-6. No abstract available.

PMID:
16533744
16.

[Successful immunosuppressive therapy for a patient with hypoplastic myelodysplastic syndrome].

Takanashi M, Kadono Y, Tabata Y, Hibi S.

Rinsho Ketsueki. 1999 Oct;40(10):1093-9. Japanese.

PMID:
10565227
17.

Determining which patients with myelodysplastic syndrome will respond to immunosuppressive treatment.

Barrett J, Sloand E, Young N.

Haematologica. 2006 May;91(5):583-4. No abstract available.

18.

Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes.

Molldrem JJ, Leifer E, Bahceci E, Saunthararajah Y, Rivera M, Dunbar C, Liu J, Nakamura R, Young NS, Barrett AJ.

Ann Intern Med. 2002 Aug 6;137(3):156-63.

PMID:
12160363
19.

Donor lymphocyte infusion for a patient with relapsing myelodysplastic syndrome after allogeneic bone marrow transplantation.

Bressoud A, Chapuis B, Roux E, Cabrol C, Jeannet M, Roosnek E, Helg C.

Blood. 1996 Sep 1;88(5):1902-3. No abstract available.

20.

Treatment of myelodysplastic syndromes.

Stadler M, Ganser A.

N Engl J Med. 2005 May 19;352(20):2134-5; author reply 2134-5. No abstract available.

PMID:
15906434

Supplemental Content

Support Center